A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

Clinical trial NCT02395601 · COMPLETED

Trial details

NCT number: NCT02395601
Sponsor: Constellation Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma

Start date: 2015-03-01
Primary completion: 2018-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.